Compare PSTL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSTL | CTKB |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.7M | 541.1M |
| IPO Year | 2018 | 2021 |
| Metric | PSTL | CTKB |
|---|---|---|
| Price | $24.79 | $4.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $20.19 | $5.63 |
| AVG Volume (30 Days) | 406.0K | ★ 2.2M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.62% | N/A |
| EPS Growth | ★ 123.81 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | $95,823,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $18.01 | $5.42 |
| Revenue Next Year | $11.38 | $7.03 |
| P/E Ratio | $225.45 | ★ N/A |
| Revenue Growth | ★ 25.47 | 17.67 |
| 52 Week Low | $13.59 | $3.09 |
| 52 Week High | $25.22 | $6.18 |
| Indicator | PSTL | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 64.52 | 62.32 |
| Support Level | $22.16 | $4.56 |
| Resistance Level | N/A | $4.80 |
| Average True Range (ATR) | 0.69 | 0.22 |
| MACD | 0.13 | 0.07 |
| Stochastic Oscillator | 85.76 | 90.82 |
Postal Realty Trust Inc is an internally managed real estate investment trust. It is engaged in acquiring and managing properties mainly leased to the United States Postal Service, or the USPS, ranging from last-mile post offices to industrial facilities. The Trust's objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of its revenue is generated in the form of rental income.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.